TECENTRIQ RESOURCES
BREAST CANCER
![Breast cancer biomarker testing article](/content/dam/tecentriq-2/en/resources/whats-next-in-breast-cancer.png)
What’s next in breast cancer biomarker testing?
![Brochure for nurses about the administration of TECENTRIQ combination therapy in TNBC](/content/dam/tecentriq-2/en/resources/tecentriq-dosing-guide-2023-sc2-1.png)
Download therapy administration
overview and dosing option
![Patient information brochure about treatment with TECENTRIQ combination therapy for TNBC.](/content/dam/tecentriq-2/en/resources/patient-information-brochure.png)
Patient information brochure
UROTHELIAL CARCINOMA
![The SAUL study publication.](/content/dam/tecentriq-2/en/resources/stenberg.png)
Free ePrint (SAUL) Sternberg et al., Eur Urology (2019)
![The SAUL study slide deck presented at EAU 2019.](/content/dam/tecentriq-2/en/resources/saul-slidedeck.png)
Download (SAUL) slide deck presented at EAU 2019
![Brochure to illustrate TECENTRIQ therapy administration overview and dosing options.](/content/dam/tecentriq-2/en/resources/tecentriq-dosing-guide-2023-sc2-1.png)
Download therapy administration
overview and dosing option
LUNG CANCER
![Brochure to illustrate TECENTRIQ therapy administration overview and dosing options.](/content/dam/tecentriq-2/en/resources/tecentriq-dosing-guide-2023-sc2-1.png)
Download therapy administration
overview and dosing option
HEPATOCELLULAR CARCINOMA
![The IMbrave150 study publication.](/content/dam/tecentriq-2/en/resources/stenberg.png)
Free ePrint IMbrave 150
Finn R, et al. New England Journal of Medicine 2020
![Brochure to illustrate TECENTRIQ therapy administration overview and dosing options.](/content/dam/tecentriq-2/en/resources/tecentriq-dosing-guide-2023-sc2-1.png)
Download therapy administration
overview and dosing option